Sands Capital Ventures, LLC Long-Term Concentrated

CIK: 0001846444 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 9, 2022

Total Value ($000): $344,073 (100.0% shares, 0.0% debt)

Holdings (18)

— DICE THERAPEUTICS, INC. 18.6%

Value ($000) $63,861 Shares 3,148,970 Est. Cost $32.75 Unrealized —

PATH UIPATH INC 14.0%

Value ($000) $48,067 Shares 3,811,779 Est. Cost $60.53 Unrealized -71.0%

NU NU HOLDINGS LTD. 11.7%

Value ($000) $40,202 Shares 9,136,835 Est. Cost $9.82 Unrealized -53.2%

SNOW SNOWFLAKE INC 10.6%

Value ($000) $36,477 Shares 214,621 Est. Cost $284.41 Unrealized -41.8%

ABOS ACUMEN PHARMACEUTICALS, INC 10.0%

Value ($000) $34,273 Shares 3,417,075 Est. Cost $16.64 Unrealized -65.5%

— SAMSARA, INC. 9.5%

Value ($000) $32,737 Shares 2,712,256 Est. Cost $28.11 Unrealized —

DASH DOORDASH INC 8.6%

Value ($000) $29,742 Shares 601,454 Est. Cost $191.28 Unrealized -65.1%

TXG 10X Genomics, Inc. 4.0%

Value ($000) $13,721 Shares 481,770 Est. Cost $51.88 Unrealized -26.6%

— KARUNA THERAPEUTICS, INC. 3.9%

Value ($000) $13,247 Shares 58,895 Est. Cost $122.33 Unrealized —

— OLINK HOLDING AB 2.5%

Value ($000) $8,565 Shares 705,514 Est. Cost $16.68 Unrealized —

MASS 908 DEVICES INC 1.6%

Value ($000) $5,370 Shares 326,427 Est. Cost $33.97 Unrealized -42.8%

TARS TARSUS PHARMACEUTICALS INC 1.3%

Value ($000) $4,451 Shares 260,000 Est. Cost $24.75 Unrealized -35.8%

RGEN REPLIGEN CORP. 1.2%

Value ($000) $4,218 Shares 22,544 Est. Cost $256.54 Unrealized -17.8%

IOT SAMSARA, INC. 1.1%

Value ($000) $3,935 Shares 326,000 Est. Cost $26.05 Unrealized -45.6%

CADL CANDEL THERAPEUTICS, INC 0.7%

Value ($000) $2,549 Shares 811,737 Est. Cost $8.29 Unrealized -59.1%

TSHA TAYSHA GENE THERAPIES INC 0.4%

Value ($000) $1,399 Shares 724,873 Est. Cost $19.01 Unrealized -80.9%

— SPRUCE BIOSCIENCES INC 0.3%

Value ($000) $1,078 Shares 787,007 Est. Cost $6.01 Unrealized —

ABSI ABSCI CORP. 0.1%

Value ($000) $181 Shares 57,804 Est. Cost $19.41 Unrealized -81.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	DICE THERAPEUTICS, INC.	3,148,970	$63,861	18.6%	$32.75	—	COM	23345J104
PATH	UIPATH INC	3,811,779	$48,067	14.0%	$60.53	-71.0%	COM CL A	90364P105
NU	NU HOLDINGS LTD.	9,136,835	$40,202	11.7%	$9.82	-53.2%	COM CL A	G6683N103
SNOW	SNOWFLAKE INC	214,621	$36,477	10.6%	$284.41	-41.8%	COM CL A	833445109
ABOS	ACUMEN PHARMACEUTICALS, INC	3,417,075	$34,273	10.0%	$16.64	-65.5%	COM	00509G209
—	SAMSARA, INC.	2,712,256	$32,737	9.5%	$28.11	—	COM CL B	FDS1Q2O30
DASH	DOORDASH INC	601,454	$29,742	8.6%	$191.28	-65.1%	COM CL A	25809K105
TXG	10X Genomics, Inc.	481,770	$13,721	4.0%	$51.88	-26.6%	COM CL A	88025U109
—	KARUNA THERAPEUTICS, INC.	58,895	$13,247	3.9%	$122.33	—	COM	48576A100
—	OLINK HOLDING AB	705,514	$8,565	2.5%	$16.68	—	COM	680710100
MASS	908 DEVICES INC	326,427	$5,370	1.6%	$33.97	-42.8%	COM	65443P102
TARS	TARSUS PHARMACEUTICALS INC	260,000	$4,451	1.3%	$24.75	-35.8%	COM	87650L103
RGEN	REPLIGEN CORP.	22,544	$4,218	1.2%	$256.54	-17.8%	COM	759916109
IOT	SAMSARA, INC.	326,000	$3,935	1.1%	$26.05	-45.6%	COM CL A	79589L106
CADL	CANDEL THERAPEUTICS, INC	811,737	$2,549	0.7%	$8.29	-59.1%	COM	137404109
TSHA	TAYSHA GENE THERAPIES INC	724,873	$1,399	0.4%	$19.01	-80.9%	COM	877619106
—	SPRUCE BIOSCIENCES INC	787,007	$1,078	0.3%	$6.01	—	COM	85209E109
ABSI	ABSCI CORP.	57,804	$181	0.1%	$19.41	-81.1%	COM	00091E109